Devimistat (CPI-613)

Devimistat (CPI-613), a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase in NCI-H460 cell line, disrupts tumor cell mitochondrial metabolism. CPI-613 induces apoptosis in pancreatic cancer cells. Phase 2.

Price Not Available 10mM/1mL Devimistat (CPI-613) Supplier Page

Trivial name	N/A
Catalog Number	S2776
Molecular Formula	C28H29Cl2N3OS
CAS#	95809-78-2
Inchi	InChI=1S/C28H28ClN3OS.ClH/c1-30-22-9-11-23(12-10-22)32(28(33)27-26(29)24-7-2-3-8-25(24)34-27)18-19-5-4-6-21(17-19)20-13-15-31-16-14-20;/h2-8,13-17,22-23,30H,9-12,18H2,1H3;1H/t22-,23?;
Inchi Key	CRWTYWYPPITOOZ-XFNHMIAXSA-N
SMILES	CNC1CCC(CC1)N(CC2=CC(=CC=C2)C3=CC=NC=C3)C(=O)C4=C(C5=CC=CC=C5S4)Cl.Cl
Size	10mM/1mL
Supplier Page	http://www.selleckchem.com/products/cpi-613.html
Additional Information	https://file.selleck.cn/downloads/struct/CPI-613-chemical-structure-s2776.gif